Risk compensation after COVID‐19 vaccination: Evidence from vaccine rollout by exact birth date in South Korea

Jisoo Hwang, Seung‐sik Hwang, Hyuncheol Bryant Kim (), Jungmin Lee and Junseok Lee

Health Economics, 2024, vol. 33, issue 8, 1811-1830

Abstract: We utilize the phased rollout of COVID‐19 vaccines by exact birth date in South Korea as a natural experiment for testing risk compensation. People may resume face‐to‐face social activities following vaccination because they perceive lower risk of infection. Applying a regression discontinuity design based on birth date cutoffs for vaccine eligibility, we find no evidence of risk‐compensating behaviors, as measured by large, high‐frequency data from credit card and airline companies as well as survey data. We find some evidence of self‐selection into vaccine take‐up based on perception toward vaccine effectiveness and side effects, but the treatment effects do not differ between compliers and never‐takers.

Date: 2024
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
https://doi.org/10.1002/hec.4837

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:wly:hlthec:v:33:y:2024:i:8:p:1811-1830

Access Statistics for this article

Health Economics is currently edited by Alan Maynard, John Hutton and Andrew Jones

More articles in Health Economics from John Wiley & Sons, Ltd.
Bibliographic data for series maintained by Wiley Content Delivery ().